Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-05-02
4:02 pm
Purchase
13GBicycle Therapeutics plc
BCYC
Logos Global Management LP1,550,000
5.2%
680,000increase
(+78.16%)
View
2022-03-14
09:29 am
Sale
13DBicycle Therapeutics plc
BCYC
TYBOURNE CAPITAL MANAGEMENT (HK) LTD1,408,259
4.8%
-549,702decrease
(-28.08%)
View
2022-02-14
4:40 pm
Purchase
13GBicycle Therapeutics plc
BCYC
Point72 Asset Management, L.P.1,572,823
5.3%
135,247increase
(+9.41%)
View
2022-02-14
4:13 pm
Purchase
13GBicycle Therapeutics plc
BCYC
Ridgeback Capital Investments L.P.2,164,801
7.4%
302,968increase
(+16.27%)
View
2022-02-14
3:16 pm
Sale
13GBicycle Therapeutics plc
BCYC
Logos Global Management LP870,000
3%
-630,000decrease
(-42.00%)
View
2022-02-11
4:32 pm
Sale
13GBicycle Therapeutics plc
BCYC
Novartis Bioventures Ltd673,360
2.29%
-967,786decrease
(-58.97%)
View
2022-02-11
1:58 pm
Purchase
13GBicycle Therapeutics plc
BCYC
JANUS HENDERSON GROUP PLC
JHG
1,695,409
5.8%
1,695,409increase
(New Position)
View
2022-01-27
4:35 pm
Purchase
13GBicycle Therapeutics plc
BCYC
Deep Track Capital, LP1,496,138
5.09%
1,496,138increase
(New Position)
View
2021-09-16
5:22 pm
Sale
13DBicycle Therapeutics plc
BCYC
GSK PLC1,529,561
6%
-86,734decrease
(-5.37%)
View
2021-08-16
11:19 am
Sale
13DBicycle Therapeutics plc
BCYC
SVLSF V, LLC1,562,451
6.49%
-352,823decrease
(-18.42%)
View
2021-07-28
7:32 pm
Purchase
13GBicycle Therapeutics plc
BCYC
Logos Global Management LP1,500,000
6.2%
1,500,000increase
(New Position)
View
2021-04-16
4:17 pm
Sale
13DBicycle Therapeutics plc
BCYC
GSK PLC1,616,295
7%
-278,536decrease
(-14.70%)
View
2021-02-16
4:17 pm
Purchase
13GBicycle Therapeutics plc
BCYC
Ridgeback Capital Investments L.P.1,861,833
8.7%
717,200increase
(+62.66%)
View
2021-02-16
3:25 pm
Purchase
13GBicycle Therapeutics plc
BCYC
Point72 Asset Management, L.P.1,437,576
6.7%
334,600increase
(+30.34%)
View
2021-02-02
1:00 pm
Sale
13GBicycle Therapeutics plc
BCYC
Atlas Venture Fund VIII, L.P.612,696
2.88%
-750,000decrease
(-55.04%)
View
2021-02-01
5:14 pm
Sale
13GBicycle Therapeutics plc
BCYC
Novartis Bioventures Ltd1,641,146
7.7%
-126,995decrease
(-7.18%)
View
2021-01-20
4:30 pm
Sale
13DBicycle Therapeutics plc
BCYC
Vertex Global HC Fund I Pte. Ltd.883,475
4.15%
-737,693decrease
(-45.50%)
View
2020-12-07
5:06 pm
Sale
13DBicycle Therapeutics plc
BCYC
GSK PLC1,894,831
8.9%
-20,444decrease
(-1.07%)
View
2020-11-12
09:11 am
Unchanged
13DBicycle Therapeutics plc
BCYC
TYBOURNE CAPITAL MANAGEMENT (HK) LTD1,957,961
9.2%
0
(Unchanged)
View
2020-09-15
4:32 pm
Purchase
13GBicycle Therapeutics plc
BCYC
Point72 Asset Management, L.P.1,102,976
5.7%
1,102,976increase
(New Position)
View
Goto 0, 1, Next